|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 294.30 USD | +2.81% |
|
+0.78% | -25.99% |
| Capitalization | 39.29B 33.89B 31.04B 29.34B 54.08B 3,804B 55.44B 370B 144B 1,791B 147B 144B 6,253B | P/E ratio 2026 * |
39.3x | P/E ratio 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise value | 36.13B 31.16B 28.54B 26.97B 49.72B 3,498B 50.97B 340B 132B 1,647B 136B 133B 5,749B | EV / Sales 2026 * |
6.44x | EV / Sales 2027 * | 4.66x |
| Free-Float |
99.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alnylam Pharmaceuticals, Inc.
| 1 day | +2.81% | ||
| 1 week | +0.78% | ||
| Current month | -4.91% | ||
| 1 month | -4.96% | ||
| 3 months | -13.28% | ||
| 6 months | -36.13% | ||
| Current year | -25.99% |
| 1 week | 284.38 |  | 298 |
| 1 month | 284.28 | | 317.56 |
| Current year | 284.28 | | 427.05 |
| 1 year | 284.19 | | 495.55 |
| 3 years | 141.98 | | 495.55 |
| 5 years | 117.58 | | 495.55 |
| 10 years | 31.38 | | 495.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2021-12-31 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 58 | 2019-08-12 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 80 | 2012-04-22 |
Amy Schulman
CHM | Chairman | 65 | 2023-01-04 |
David Pyott
BRD | Director/Board Member | 72 | 2015-12-17 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.81% | +0.78% | +0.84% | +54.29% | 39.29B | |
| +3.37% | +3.19% | +35.27% | +130.89% | 911B | |
| +0.47% | +2.56% | +50.83% | +44.74% | 554B | |
| +2.08% | +2.84% | +15.10% | +47.31% | 378B | |
| +1.27% | +0.40% | +24.15% | +11.99% | 333B | |
| -0.09% | +0.45% | +32.73% | +14.89% | 288B | |
| -0.12% | +1.66% | +27.28% | +30.14% | 287B | |
| +1.49% | +1.66% | +47.92% | -1.08% | 282B | |
| -0.32% | -4.53% | -37.38% | -51.58% | 198B | |
| +1.96% | -1.65% | +19.90% | +48.04% | 179B | |
| Average | +1.32% | +1.32% | +21.66% | +32.96% | 344.87B | |
| Weighted average by Cap. | +1.56% | +2.12% | +29.29% | +51.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.61B 4.84B 4.44B 4.19B 7.73B 543B 7.92B 52.85B 20.58B 256B 21.06B 20.62B 893B | 7.3B 6.3B 5.77B 5.45B 10.05B 707B 10.3B 68.75B 26.78B 333B 27.4B 26.82B 1,162B |
| Net income | 1.03B 885M 810M 766M 1.41B 99.3B 1.45B 9.66B 3.76B 46.75B 3.85B 3.77B 163B | 1.52B 1.31B 1.2B 1.13B 2.09B 147B 2.14B 14.28B 5.56B 69.14B 5.69B 5.57B 241B |
| Net Debt | -3.17B -2.73B -2.5B -2.36B -4.36B -307B -4.47B -29.81B -11.61B -144B -11.88B -11.63B -504B | -5.26B -4.54B -4.16B -3.93B -7.24B -509B -7.42B -49.54B -19.29B -240B -19.75B -19.33B -837B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-19 | 294.30 $ | +2.81% | 770,339 |
| 26-05-18 | 286.27 $ | -0.25% | 873,361 |
| 26-05-15 | 286.98 $ | -2.20% | 1,149,640 |
| 26-05-14 | 293.45 $ | +0.68% | 889,670 |
| 26-05-13 | 291.48 $ | -0.19% | 975,853 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALNY Stock
Select your edition
All financial news and data tailored to specific country editions
